|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 9294 |
FusionGeneSummary for DAPK2_MAP2K5 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: DAPK2_MAP2K5 | Fusion gene ID: 9294 | Hgene | Tgene | Gene symbol | DAPK2 | MAP2K5 | Gene ID | 23604 | 5607 |
| Gene name | death associated protein kinase 2 | mitogen-activated protein kinase kinase 5 | |
| Synonyms | DRP-1|DRP1 | HsT17454|MAPKK5|MEK5|PRKMK5 | |
| Cytomap | 15q22.31 | 15q23 | |
| Type of gene | protein-coding | protein-coding | |
| Description | death-associated protein kinase 2DAP kinase 2DAP-kinase-related protein 1 beta isoform | dual specificity mitogen-activated protein kinase kinase 5MAP kinase kinase 5MAP kinase kinase MEK5bMAPK/ERK kinase 5MAPKK 5MEK 5 | |
| Modification date | 20180526 | 20180523 | |
| UniProtAcc | Q9UIK4 | Q13163 | |
| Ensembl transtripts involved in fusion gene | ENST00000261891, ENST00000457488, ENST00000558069, ENST00000558482, | ENST00000178640, ENST00000560591, ENST00000395476, ENST00000354498, ENST00000340972, | |
| Fusion gene scores | * DoF score | 5 X 5 X 4=100 | 8 X 7 X 9=504 |
| # samples | 9 | 13 | |
| ** MAII score | log2(9/100*10)=-0.15200309344505 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/504*10)=-1.95491211047146 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: DAPK2 [Title/Abstract] AND MAP2K5 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | DAPK2 | GO:0006468 | protein phosphorylation | 10376525 |
| Hgene | DAPK2 | GO:0035556 | intracellular signal transduction | 10376525 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AI692764 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + | ||
| ChiTaRS3.1 | BE464504 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + | ||
| ChiTaRS3.1 | BE328057 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + | ||
| ChiTaRS3.1 | AW013877 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000261891 | ENST00000178640 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000261891 | ENST00000560591 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000261891 | ENST00000395476 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000261891 | ENST00000354498 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000261891 | ENST00000340972 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| In-frame | ENST00000457488 | ENST00000178640 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000457488 | ENST00000560591 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000457488 | ENST00000395476 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000457488 | ENST00000354498 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000457488 | ENST00000340972 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| In-frame | ENST00000558069 | ENST00000178640 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000558069 | ENST00000560591 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000558069 | ENST00000395476 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000558069 | ENST00000354498 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5CDS-intron | ENST00000558069 | ENST00000340972 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5UTR-3CDS | ENST00000558482 | ENST00000178640 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5UTR-intron | ENST00000558482 | ENST00000560591 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5UTR-intron | ENST00000558482 | ENST00000395476 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5UTR-intron | ENST00000558482 | ENST00000354498 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
| 5UTR-intron | ENST00000558482 | ENST00000340972 | DAPK2 | chr15 | 64332368 | - | MAP2K5 | chr15 | 68098982 | + |
Top |
FusionProtFeatures for DAPK2_MAP2K5 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| DAPK2 | MAP2K5 |
| Calcium/calmodulin-dependent serine/threonine kinaseinvolved in multiple cellular signaling pathways that trigger cellsurvival, apoptosis, and autophagy. Regulates both type Iapoptotic and type II autophagic cell death signals, depending onthe cellular setting. The former is caspase-dependent, while thelatter is caspase-independent and is characterized by theaccumulation of autophagic vesicles. Acts as a mediator of anoikisand a suppressor of beta-catenin-dependent anchorage-independentgrowth of malignant epithelial cells. May play a role ingranulocytic maturation (PubMed:17347302). Regulates granulocyticmotility by controlling cell spreading and polarization(PubMed:24163421). {ECO:0000269|PubMed:17347302,ECO:0000269|PubMed:24163421, ECO:0000269|PubMed:26047703}. Isoform 2 is not regulated by calmodulin. It canphosphorylate MYL9. It can induce membrane blebbing and autophagiccell death. | Acts as a scaffold for the formation of a ternaryMAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of thispathway appears to play a critical role in protecting cells fromstress-induced apoptosis, neuronal survival and cardiacdevelopment and angiogenesis. {ECO:0000269|PubMed:7759517,ECO:0000269|PubMed:9384584}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for DAPK2_MAP2K5 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_DAPK2_ENST00000457488_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG >In-frame_DAPK2_ENST00000558069_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG >In-frame_DAPK2_ENST00000457488_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG >In-frame_DAPK2_ENST00000558069_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG >In-frame_DAPK2_ENST00000457488_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG >In-frame_DAPK2_ENST00000558069_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG >In-frame_DAPK2_ENST00000457488_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG >In-frame_DAPK2_ENST00000558069_chr15_64332368_-_MAP2K5_ENST00000178640_chr15_68098982_+_601nt GACCGCGGCAGCTCAGCCTCCCGCCGATTGTATGTTCCAGGCCTCAATGAGGAGTCCAAACATGGAGCCATTCAAGCAGCAGAAGGTGGA GGACTTTTATGACATCGGAGAGGAGCTGGGGAGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGG GTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGAGGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGG AGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAGAGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTC TGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCACCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACT GGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTCCCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGG |
Top |
FusionGenePPI for DAPK2_MAP2K5 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| DAPK2 | DAPK2, APP, FAM9B, LLGL2, RACGAP1, TUBGCP5, KLC3 | MAP2K5 | MAP3K3, MAP3K2, PRKCZ, MAPK7, MAP2K5, YWHAZ, CDC42BPB, ENO1, SQSTM1, ASRGL1, STAMBP, PRKCI, PARD6A, HSP90AA1, GCH1, XRCC6, ESRRA, RPL28, NXF1, LNX2, TRAF7, C10orf88, CDC37 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for DAPK2_MAP2K5 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for DAPK2_MAP2K5 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | MAP2K5 | C0005910 | Body Weight | 1 | CTD_human |
| Tgene | MAP2K5 | C0011581 | Depressive disorder | 1 | PSYGENET |
| Tgene | MAP2K5 | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|